DiscoverThe ExecutiveFrom Deep Analytics to Leading Post IPO: Molly Harper, Chief Business Officer of Synlogic
From Deep Analytics to Leading Post IPO: Molly Harper, Chief Business Officer of Synlogic

From Deep Analytics to Leading Post IPO: Molly Harper, Chief Business Officer of Synlogic

Update: 2023-04-21
Share

Description


Molly Harper, Chief Business Officer of Synlogic, a biotechnology company that went public in 2021 through a reverse merger with Mirna Therapeutics raising an additional $40M after $100M in venture capital funding. Molly is also a member of the Board of Directors for Catalyst Pharmaceuticals and PreciseDX. Molly attended Wharton for her MBA, Healthcare Management, and Bachelor of Arts from Cornell University.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From Deep Analytics to Leading Post IPO: Molly Harper, Chief Business Officer of Synlogic

From Deep Analytics to Leading Post IPO: Molly Harper, Chief Business Officer of Synlogic

Matt Harbert